Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mickael Jean

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Frontiers in Cell and Developmental Biology|May 21, 2020
CD95 Structure, Aggregation and Cell SignalingNicolas Levoin, Mickael Jean, Patrick Legembre
Biochimica Et Biophysica Acta. Reviews on Cancer|October 21, 2023
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathwaysLayla Haymour, Mickael Jean, Cristian Smulski, et al.
Organic Letters|December 2, 2011
The Prins reaction using ketones: rationalization and application toward the synthesis of the portentol skeletonMaiwenn Jacolot, Mickael Jean, Nicolas Levoin, et al.
Recent Patents on Anti-Cancer Drug Discovery|May 20, 2016
Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast CancersAmélie Fouqué, Mickael Jean, Pierre van de Weghe, et al.
Frontiers in Immunology|December 22, 2022
Role of metalloproteases in the CD95 signaling pathwaysLaurent Devel, Nicolas Guedeney, Sarah Bregant, et al.
The Journal of Organic Chemistry|June 19, 2013
Synthesis of stachybotrin C and all of its stereoisomers: structure revisionMaiwenn Jacolot, Mickael Jean, Naresh Tumma, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|July 29, 2021
Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?Keerthi Kurma, Andrea Boizard-Moracchini, Gael Galli, et al.
European Journal of Immunology|October 14, 2023
CD95L concatemers highlight different stoichiometries of CD95-mediated apoptotic and nonapoptotic pathwaysEden Lebrault, Christelle Oblet, Keerthi Kurma, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2019
Probing the side chain tolerance for inhibitors of the CD95/PLCγ1 interactionHa Thanh Nguyen, Jean-Philippe Guégan, Daniel Best, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2019
Synthesis of peptidomimetics and chemo-biological tools for CD95/PLCγ1 interaction analysisHa Thanh Nguyen, Jean-Philippe Guégan, Amanda Poissonnier, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Cell and Developmental Biology|May 21, 2020
CD95 Structure, Aggregation and Cell SignalingNicolas Levoin, Mickael Jean, Patrick Legembre
Biochimica Et Biophysica Acta. Reviews on Cancer|October 21, 2023
CD95 (Fas) and CD95L (FasL)-mediated non-canonical signaling pathwaysLayla Haymour, Mickael Jean, Cristian Smulski, et al.
Organic Letters|December 2, 2011
The Prins reaction using ketones: rationalization and application toward the synthesis of the portentol skeletonMaiwenn Jacolot, Mickael Jean, Nicolas Levoin, et al.
Recent Patents on Anti-Cancer Drug Discovery|May 20, 2016
Review of PI3K/mTOR Inhibitors Entering Clinical Trials to Treat Triple Negative Breast CancersAmélie Fouqué, Mickael Jean, Pierre van de Weghe, et al.
Frontiers in Immunology|December 22, 2022
Role of metalloproteases in the CD95 signaling pathwaysLaurent Devel, Nicolas Guedeney, Sarah Bregant, et al.
The Journal of Organic Chemistry|June 19, 2013
Synthesis of stachybotrin C and all of its stereoisomers: structure revisionMaiwenn Jacolot, Mickael Jean, Naresh Tumma, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|July 29, 2021
Soluble CD95L in cancers and chronic inflammatory disorders, a new therapeutic target?Keerthi Kurma, Andrea Boizard-Moracchini, Gael Galli, et al.
European Journal of Immunology|October 14, 2023
CD95L concatemers highlight different stoichiometries of CD95-mediated apoptotic and nonapoptotic pathwaysEden Lebrault, Christelle Oblet, Keerthi Kurma, et al.
Bioorganic & Medicinal Chemistry Letters|September 19, 2019
Probing the side chain tolerance for inhibitors of the CD95/PLCγ1 interactionHa Thanh Nguyen, Jean-Philippe Guégan, Daniel Best, et al.
Bioorganic & Medicinal Chemistry Letters|July 15, 2019
Synthesis of peptidomimetics and chemo-biological tools for CD95/PLCγ1 interaction analysisHa Thanh Nguyen, Jean-Philippe Guégan, Amanda Poissonnier, et al.
Pageof 2